Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Influence of low penetrant factors on overall cancer risk

Prof Douglas Easton – Cancer Research UK Genetic Epidemiology Unit, Cambridge University, UK
Influence of low penetrant factors on overall cancer risk ( Prof Douglas Easton – Cancer Research UK Genetic Epidemiology Unit, Cambridge University, UK )
16 Dec 2012

Links between EGFR/HER1 signalling and trastuzumab efficacy

Dr David Rimm – Yale University, New Haven, USA
Links between EGFR/HER1 signalling and trastuzumab efficacy ( Dr David Rimm – Yale University, New Haven, USA )
16 Dec 2012

Pomalidomide with low-dose vs. high-dose dexamathasone in refractory patients

Professor Meletios Dimopoulos - University of Athens, Greece
Pomalidomide with low-dose vs. high-dose dexamathasone in refractory patients ( Professor Meletios Dimopoulos - University of Athens, Greece )
16 Dec 2012

MLN9708 in combination with lenalidomide and dexamethasone

Dr Shaji Kumar - Mayo Clinic, Rochester, USA
MLN9708 in combination with lenalidomide and dexamethasone ( Dr Shaji Kumar - Mayo Clinic, Rochester, USA )
16 Dec 2012

History of epidermal stem cell use in the clinical setting

Prof Michele De Luca - University of Modena e Reggio Emilia, Modena, Italy
History of epidermal stem cell use in the clinical setting ( Prof Michele De Luca - University of Modena e Reggio Emilia, Modena, Italy )
14 Dec 2012

Effects of obesity in breast cancer patients

Dr Clifford Hudis – Memorial Sloan Kettering Cancer Center, New York, USA
Effects of obesity in breast cancer patients ( Dr Clifford Hudis – Memorial Sloan Kettering Cancer Center, New York, USA )
14 Dec 2012

The AZURE translational study

Prof Robert Coleman - Weston Park Hospital, University of Sheffield, UK
The AZURE translational study ( Prof Robert Coleman	 - Weston Park Hospital, University of Sheffield, UK )
14 Dec 2012

Diagnosis of blood cancer after a breast cancer diagnosis

Prof Antonio Wolff - The Johns Hopkins Hospital, Baltimore, USA
Diagnosis of blood cancer after a breast cancer diagnosis ( Prof Antonio Wolff - The Johns Hopkins Hospital, Baltimore, USA )
14 Dec 2012

HDAC inhibition sensitises triple-negative breast cancer cells to PARP inhibition

Dr Kapil Bhalla - University of Kansas Cancer Center, Kansas City, USA
HDAC inhibition sensitises triple-negative breast cancer cells to PARP inhibition ( Dr Kapil Bhalla - University of Kansas Cancer Center, Kansas City, USA )
13 Dec 2012

Neratinib shows beneficial effects in the treatment of HER2 mutated breast cancer

Prof Ron Bose – Washington University School of Medicine, St. Louis, USA
Neratinib shows beneficial effects in the treatment of HER2 mutated breast cancer ( Prof Ron Bose – Washington University School of Medicine, St. Louis, USA )
12 Dec 2012

Breast cancer genome sequencing identified HER2 mutations as targets for drug treatment

Prof Ron Bose - Washington University School of Medicine, St Louis, USA
Breast cancer genome sequencing identified HER2 mutations as targets for drug treatment ( Prof Ron Bose - Washington University School of Medicine, St Louis, USA )
12 Dec 2012

Cognitive problems may be present before chemotherapy in women with breast cancer

Prof Bernadine Cimprich - University of Michigan School of Nursing, Ann Arbor, USA
Cognitive problems may be present before chemotherapy in women with breast cancer ( Prof Bernadine Cimprich - University of Michigan School of Nursing, Ann Arbor, USA )
12 Dec 2012